Revvity | PKI - Ebit



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.21B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


Ebit 更改 日
Agilent USD 399M 46M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 941.3M 1.36B 2025-12
Bruker USD 10.2M 66.1M 2026-03
Celltrion KRW 12.08B 288.96B 2025-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Illumina USD 239M 17M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Mesa Laboratories USD 4.45M 2.5M 2024-09
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pharma Mar EUR 622K 42.99M 2026-03
Qiagen NV USD 121.88M 19.18M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -27.4M 9.9M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Sartorius EUR 160.7M 94.1M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Waters USD 148M 122.52M 2026-03
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03